RECRUITINGOBSERVATIONAL

Predictive Value of Modified Caprini Score and D-Dimer in Managing Lower Limb Venous Thrombosis in Cardiothoracic Patients

Predictive Efficacy of Modified Caprini Score and D-Dimer for the Evaluation and Management of Lower Extremity Venous Thrombosis Among Cardiothoracic Surgery Patients in Baghdad

About This Trial

The goal of this observational study is to evaluate the predictive efficacy of the Modified Caprini Risk Assessment Score and D-Dimer in identifying and managing lower extremity venous thrombosis (LEVT) among cardiothoracic surgery patients in Baghdad. The main questions it aims to answer are: Does combining the Modified Caprini Score with D-Dimer improve the accuracy of predicting lower extremity venous thrombosis (LEVT) compared to using each tool independently? Can these tools effectively guide clinical decisions for lower extremity venous thrombosis (LEVT) prevention and management in this patient population? Participants will: Undergo risk assessment for lower extremity venous thrombosis (LEVT) using the Modified Caprini Score and have their D-Dimer levels measured during their hospital stay. Be monitored for clinical outcomes, including confirmed lower extremity venous thrombosis (LEVT) incidence, need for anticoagulation therapy, and complications such as pulmonary embolism or recurrent thrombosis.

Who May Be Eligible (Plain English)

Who May Qualify: - Inpatients with a hospital stay over 3 days - Written willing to sign a consent form obtained from patients or their legal guardians. - Availability for postoperative follow-up to assess outcomes like LEVT development or related complications. Who Should NOT Join This Trial: - Preexisting LEVT or Pulmonary Embolism: Diagnosed before the index surgery. - Severe Coagulopathy: Patients with inherited or acquired bleeding disorders (e.g., hemophilia, advanced liver disease). - receiving any anticoagulation therapy for any reason. - patients who did not undergo a postoperative D-dimer test. - Incomplete Data: missing essential clinical or laboratory data for Modified Caprini Score calculation or D-Dimer measurement. - Pregnancy: pregnant women or those within six weeks postpartum. - Noncompliance: Patients unwilling or unable to adhere to study follow-up protocols. Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language

Inclusion Criteria: * Inpatients with a hospital stay over 3 days * Written informed consent obtained from patients or their legal guardians. * Availability for postoperative follow-up to assess outcomes like LEVT development or related complications. Exclusion Criteria: * Preexisting LEVT or Pulmonary Embolism: Diagnosed before the index surgery. * Severe Coagulopathy: Patients with inherited or acquired bleeding disorders (e.g., hemophilia, advanced liver disease). * receiving any anticoagulation therapy for any reason. * patients who did not undergo a postoperative D-dimer test. * Incomplete Data: missing essential clinical or laboratory data for Modified Caprini Score calculation or D-Dimer measurement. * Pregnancy: pregnant women or those within six weeks postpartum. * Noncompliance: Patients unwilling or unable to adhere to study follow-up protocols.

Treatments Being Tested

DEVICE

GCS

Graduated compression stockings may be used after procedure by the decision of the doctor

DRUG

LMWH

Low-molecular-weight heparin may be used after procedure by the decision of the doctor

Locations (1)

College of Medicine - Al-Nahrain University

Baghdad, Iraq